Live Analyst Rating Changes 22967 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Aaron Grey
AG

Aaron Grey

Alliance Global Partners
Wall Street Analyst
★☆☆☆☆
#3092
on 13Foresight · ranked by our own returns
31%
Success Rate
-17.1%
Average Return
11 of 36 calls profitable · -26.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 31% of Aaron Grey's ratings turned a profit when each position was held for 2 year — averaging -17.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

60 Buy 17 Hold 0 Sell
Aaron's Stock Coverage 34 ratings · 2026-08-11
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
VFF
Village Farms International
 Aug 10, 2026 BUY Strong Buy
+290.5% avg upside
7 analysts
$5.00
111.02% Upside
 +2.5% ·
TRLV
Trulieve Cannabis
 Aug 07, 2026 BUY Strong Buy
+148.0% avg upside
15 analysts
$20.00
120.19% Upside
 +0.0% ·
TSE:CL
Cresco Labs
 Aug 06, 2026 BUY Strong Buy
+447.5% avg upside
13 analysts
$2.50
145.17% Upside
 · ·
TSE:CURA
Curaleaf Holdings
 Aug 06, 2026 BUY Strong Buy
+11.6% avg upside
13 analysts
$21.00
60.53% Upside
 +0.1% ·
HNST
Honest Company
 Aug 06, 2026 BUY Buy
-8.0% avg upside
11 analysts
$5.00
4.44% Downside
 -3.9% ·
TSE:VRNO
Verano Holdings
 Aug 05, 2026 BUY Strong Buy
+169.6% avg upside
8 analysts
$25.00
228.53% Upside
 · ·
TLRY
Tilray
 Jul 29, 2026 HOLD Hold
+88.1% avg upside
24 analysts
$5.00
13.14% Upside
 +14.5% ·
SNDL
SNDL
 Jul 28, 2026 BUY Buy
+86.6% avg upside
5 analysts
$3.50
186.79% Upside
 +2.5% ·
HFFG
HF Foods Group
 Jul 23, 2026 BUY Strong Buy
+252.5% avg upside
2 analysts
$5.00
220.45% Upside
 +2.6% ·
TPB
Turning Point Brands
 Jul 23, 2026 BUY Strong Buy
+2.7% avg upside
10 analysts
$115.00
28.66% Upside
 +22.3% ·
REFI
Chicago Atlantic Real Estate ate Finance Inc
 Jun 23, 2026 BUY Buy
+70.2% avg upside
7 analysts
$20.00
95.32% Upside
 -2.5% ·
TSE:WEED
Canopy Growth
 Jun 16, 2026 HOLD Hold
+1255.4% avg upside
23 analysts
$1.60
21.15% Upside
 +2.2% ·
NGVC
Natural Grocers
 Jun 08, 2026 BUY Strong Buy
-10.5% avg upside
4 analysts
$40.00
52.23% Upside
 -8.5% ·
BRIA
BrilliA Inc. Class A
 Jun 05, 2026 BUY Strong Buy
+99.4% avg upside
1 analyst
$2.75
99.36% Upside
 -13.2% ·
WALD
Waldencast
 Jun 04, 2026 BUY Buy
+65.1% avg upside
6 analysts
$2.50
79.91% Upside
 -15.4% ·
TRUL
Trulite
 Jun 04, 2026 BUY Strong Buy
+19175444.5% avg upside
2 analysts
$19.35
19350988.97% Upside
 · ·
REED
Reed's
 May 18, 2026 HOLD Buy
+1338.9% avg upside
5 analysts
 — -55.0% ·
GRWG
GrowGeneration
 May 13, 2026 HOLD Strong Buy
+1083.7% avg upside
9 analysts
$1.50
4.99% Upside
 -8.1% ·
TSE:OGI
Organigram Global
 May 12, 2026 BUY Buy
+210.8% avg upside
11 analysts
$4.00
179.64% Upside
 -11.0% ·
AFCG
AFC Gamma
 May 12, 2026 HOLD Buy
+400.4% avg upside
10 analysts
 — -13.4% ·
TSE:GTII
Green Thumb Industries
 May 07, 2026 BUY Strong Buy
+121.6% avg upside
15 analysts
$25.00
160.05% Upside
 · ·
IIPR
Innovative Industrial Properties
 Feb 26, 2026 HOLD Hold
+8.3% avg upside
9 analysts
$55.00
4.24% Downside
 +12.6% ·
GTII
Global Tech Industries Group
 Nov 06, 2025 BUY Strong Buy
+133093.4% avg upside
1 analyst
$15.05
133093.37% Upside
 -71.5% ·
SDOT
Sadot Group
 Mar 12, 2025 HOLD Hold
1 analyst
 — · ·
CBSTQ
Cannabist Company Holdings
 Jan 15, 2025 HOLD Strong Buy
+5177266.8% avg upside
5 analysts
 — · ·
ZSTK
ZeroStack
 Aug 15, 2024 HOLD Buy
+915.6% avg upside
4 analysts
 — -95.4% ·
UPXI
Upexi
 Feb 15, 2024 HOLD Strong Buy
+467.5% avg upside
4 analysts
$1.25
55.42% Upside
 -96.0% ·
WEED
Roundhill Cannabis ETF
 Nov 10, 2023 HOLD Hold
-96.4% avg upside
2 analysts
$0.72
96.39% Downside
 -27.8% ·
XXII
22nd Century
 Aug 17, 2023 HOLD Buy
+727.7% avg upside
3 analysts
$36.00
727.67% Upside
 · ·
GNLN
Greenlane Holdings
 Nov 16, 2022 BUY Strong Buy
+737.9% avg upside
4 analysts
$20.00
925.98% Upside
 · ·
RYM
RYTHM
 Nov 10, 2022 HOLD Buy
+151.2% avg upside
3 analysts
 — -97.9% ·
IMCC
IM Cannabis Corp
 Aug 16, 2022 BUY Strong Buy
+11438.5% avg upside
1 analyst
$15.00
11438.45% Upside
 · ·
NEPTF
Neptune Wellness Solutions
 Jul 01, 2022 HOLD Strong Buy
+402602552.0% avg upside
7 analysts
$0.57
57336460.00% Upside
 · ·
TSE:LABS
MediPharm Labs
 Apr 04, 2022 BUY Strong Buy
+7043.0% avg upside
2 analysts
$0.25
233.31% Upside
 -50.0% ·
🔒 29 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Aaron Grey — Frequently Asked Questions
How accurate are Aaron Grey's stock ratings?
Based on the calls 13Foresight could measure, about 29% of Aaron's ratings were profitable over a one-year hold, with an average return of -15.2% per rating, or -21.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Aaron ranked on 13Foresight?
Aaron Grey is currently ranked #3092 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Aaron cover?
Aaron most recently has ratings on VFF, TRLV, TSE:CL, TSE:CURA, HNST, TSE:VRNO, TLRY, SNDL, HFFG, TPB, REFI, TSE:WEED and 22 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.